Company Filing History:
Years Active: 2016-2025
Title: Brian Francis Sullivan: Innovator in Cancer Treatment
Introduction
Brian Francis Sullivan is a notable inventor based in Medina, MN (US). He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of 7 patents, Sullivan's work focuses on developing targeted therapeutic agents for cancer patients.
Latest Patents
Sullivan's latest patents include groundbreaking methods for the treatment of cancer using a specific compound known as gedatolisib. This method involves selecting a subject in need of cancer treatment and administering a therapeutically effective amount of gedatolisib at least once a week for a period of three weeks. The treatment cycle includes a one-week discontinuation before resuming administration, allowing for effective management of the disease. Another significant patent involves methods for measuring signaling pathway activity in diseased cell samples. This innovation enables the selection of therapeutic agents that target the most aberrant signaling pathways in a patient's cells, enhancing the effectiveness of treatment.
Career Highlights
Sullivan is currently associated with Celcuity Inc., a company dedicated to advancing cancer treatment through innovative research. His work at Celcuity has positioned him as a key player in the development of targeted therapies that aim to improve patient outcomes.
Collaborations
Sullivan collaborates with various professionals in the field, including his coworker Lance Gavin Laing. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
Brian Francis Sullivan's contributions to cancer treatment through his innovative patents and research at Celcuity Inc. highlight his commitment to improving patient care. His work continues to pave the way for advancements in targeted therapies, making a significant impact in the medical field.